[HTML][HTML] Supportive management of mucositis and metabolic derangements in head and neck cancer patients
M Bonomi, K Batt - Cancers, 2015 - mdpi.com
Oral mucositis (OM) is among the most undesirable, painful, and expensive toxicities of
cytotoxic cancer therapy, and is disheartening for patients and frustrating for caregivers …
cytotoxic cancer therapy, and is disheartening for patients and frustrating for caregivers …
[HTML][HTML] Supportive Management of Mucositis and Metabolic Derangements in Head and Neck Cancer Patients
M Bonomi, K Batt - Cancers, 2015 - ncbi.nlm.nih.gov
Oral mucositis (OM) is among the most undesirable, painful, and expensive toxicities of
cytotoxic cancer therapy, and is disheartening for patients and frustrating for caregivers …
cytotoxic cancer therapy, and is disheartening for patients and frustrating for caregivers …
[PDF][PDF] Supportive Management of Mucositis and Metabolic Derangements in Head and Neck Cancer Patients
M Bonomi, K Batt - Citeseer
Oral mucositis (OM) is among the most undesirable, painful, and expensive toxicities of
cytotoxic cancer therapy, and is disheartening for patients and frustrating for caregivers …
cytotoxic cancer therapy, and is disheartening for patients and frustrating for caregivers …
Supportive Management of Mucositis and Metabolic Derangements in Head and Neck Cancer Patients.
M Bonomi, K Batt - Cancers, 2015 - search.ebscohost.com
Oral mucositis (OM) is among the most undesirable, painful, and expensive toxicities of
cytotoxic cancer therapy, and is disheartening for patients and frustrating for caregivers …
cytotoxic cancer therapy, and is disheartening for patients and frustrating for caregivers …
Supportive management of mucositis and metabolic derangements in head and neck cancer patients
M Bonomi, K Batt - Cancers, 2015 - ohiostate.elsevierpure.com
Oral mucositis (OM) is among the most undesirable, painful, and expensive toxicities of
cytotoxic cancer therapy, and is disheartening for patients and frustrating for caregivers …
cytotoxic cancer therapy, and is disheartening for patients and frustrating for caregivers …
[引用][C] Supportive Management of Mucositis and Metabolic Derangements in Head and Neck Cancer Patients
M Bonomi, K Batt - Cancers, 2015 - cir.nii.ac.jp
Supportive Management of Mucositis and Metabolic Derangements in Head and Neck Cancer
Patients | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …
Patients | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …
Supportive Management of Mucositis and Metabolic Derangements in Head and Neck Cancer Patients.
M Bonomi, K Batt - Cancers, 2015 - europepmc.org
Oral mucositis (OM) is among the most undesirable, painful, and expensive toxicities of
cytotoxic cancer therapy, and is disheartening for patients and frustrating for caregivers …
cytotoxic cancer therapy, and is disheartening for patients and frustrating for caregivers …
Supportive Management of Mucositis and Metabolic Derangements in Head and Neck Cancer Patients
M Bonomi, K Batt - Cancers, 2015 - search.proquest.com
Oral mucositis (OM) is among the most undesirable, painful, and expensive toxicities of
cytotoxic cancer therapy, and is disheartening for patients and frustrating for caregivers …
cytotoxic cancer therapy, and is disheartening for patients and frustrating for caregivers …
Supportive Management of Mucositis and Metabolic Derangements in Head and Neck Cancer Patients
M Bonomi, K Batt - Cancers (Basel), 2015 - inis.iaea.org
[en] Oral mucositis (OM) is among the most undesirable, painful, and expensive toxicities of
cytotoxic cancer therapy, and is disheartening for patients and frustrating for caregivers …
cytotoxic cancer therapy, and is disheartening for patients and frustrating for caregivers …
Supportive Management of Mucositis and Metabolic Derangements in Head and Neck Cancer Patients
M Bonomi, K Batt - Cancers, 2015 - pubmed.ncbi.nlm.nih.gov
Oral mucositis (OM) is among the most undesirable, painful, and expensive toxicities of
cytotoxic cancer therapy, and is disheartening for patients and frustrating for caregivers …
cytotoxic cancer therapy, and is disheartening for patients and frustrating for caregivers …